GlassScriptPhysician profile
Ramakrishna R Kosuri
NPI 1588624498
$388.83
in general payments reported to CMS, 2019-2025
13 companies · $40.92 in 2025
The $40.92 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.24 · 2020: $47.82 · 2021: $89.78 · 2022: $19.43 · 2023: $56.27 · 2024: $39.37 · 2025: $40.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $136.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $45.93 | 2019-2020 | |
| Abbott Laboratories | $44.41 | 2019-2021 | |
| Integra Lifesciences Corporation | $40.92 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ermi LLC | $38.24 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $37.74 | 2019-2023 | Euflexxa |
| Sanofi-Aventis U.S. LLC | $37.56 | 2021-2023 | |
| Bioventus LLC | $29.95 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $21.96 | 2024 | Zilretta, Iovera |
| Stryker Corporation | $21.11 | 2023 | Tornier Perform Reversed Glenoid, Blueprint Patient Specific Instrumentation |
| Heron Therapeutics, INC. | $19.43 | 2022 | |
| Fidia Pharma USA INC. | $17.80 | 2019-2021 | |
| Medtronic, INC. | $17.41 | 2024 | Intellis Adaptivestim |
| Ibsa Pharma INC. | $16.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramakrishna Kosuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.